AbCellera Biologics Inc
Company Profile
Business description
AbCellera Biologics Inc is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company’s experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
Contact
150 W 4th Avenue
VancouverBCV5Y 1G6
CANT: +1 604 559-9005
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
596
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,149.80 | 8.90 | -0.11% |
CAC 40 | 8,042.95 | 51.25 | -0.63% |
DAX 40 | 22,891.68 | 107.47 | -0.47% |
Dow JONES (US) | 41,985.35 | 32.03 | 0.08% |
FTSE 100 | 8,646.79 | 55.20 | -0.63% |
HKSE | 23,640.85 | 48.87 | -0.21% |
NASDAQ | 17,784.05 | 92.42 | 0.52% |
Nikkei 225 | 37,676.97 | 0.09 | -0.00% |
NZX 50 Index | 12,126.65 | 13.11 | 0.11% |
S&P 500 | 5,667.56 | 4.67 | 0.08% |
S&P/ASX 200 | 7,926.50 | 4.70 | -0.06% |
SSE Composite Index | 3,364.90 | 0.07 | 0.00% |